Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-908P is a non-coding, genomic pseudogene that represents an inactive copy or remnant of the U6 small nuclear RNA gene[1][8]. While functional U6 RNA is an essential component of the spliceosome—facilitating RNA splicing during post-transcriptional modification—pseudogenes such as RNU6-908P do not contribute directly to cellular function and typically lack transcriptional activity, biological function, and relevance to drug discovery or disease mechanisms[7][8][1]. Pseudogene annotation is important for genome mapping but does not confer functional roles analogous to their parent genes.\n\nAdditional context:\n- The actual U6 small nuclear RNA performs critical functions in RNA splicing, but pseudogenes are generally evolutionary relics without active roles[3][7][5].\n- There are numerous U6-related pseudogenes in vertebrate genomes, reflecting genomic duplication and evolutionary processes rather than biological function[5][7][8].\n- Only very rarely are pseudogenes shown to have regulatory effects (e.g., on gene expression), but no such role is documented for RNU6-908P[1][8].\n\nNote: \n- If the intended target was the functional U6 snRNA or spliceosomal components, more functional data and biomedical relevance would apply[3][5].\n- The entry is correctly named and classified; however, it should not be used as a therapeutic or pharmacological target[8][1].
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 908, pseudogene (RNU6-908P).